In a Nutshell
A hot flash is a sudden surge of heat — usually in the face, neck, and chest — paired with sweating and a flushed appearance, lasting 1 to 5 minutes per episode.
Estimates of how common they are vary depending on the population studied and how symptoms are defined, but hot flashes affect more than half of women globally and up to three-quarters or more in some U.S. populations.
They often continue for several years, and in some women they last a decade or longer.
Most are manageable with a combination of lifestyle adjustments, FDA-approved hormone therapy, or newer non-hormonal medications like fezolinetant — effective treatment options are available.
What a Hot Flash Feels Like
Most women describe a hot flash as a wave of intense warmth that rises through the chest and face, often within seconds. Your skin may turn red and blotchy. You may break out in a sweat — sometimes heavy enough to soak clothing — and your heart may race.
As the heat passes, you may feel chilled, clammy, or shivery as your body temperature overcorrects. Some women feel anxious or lightheaded during an episode, and a few experience heart palpitations.
Hot flashes vary widely in severity. For some women, they're a brief inconvenience. For roughly 10-15% of women, hot flashes are severe enough to disrupt daily activities — interrupting meetings, sleep, exercise, or social events. About 1 in 3 women report having more than 10 episodes per day.
Some women experience a milder version known as a "warm flush" — a sensation of heat without drenching sweat. This is part of the same vasomotor symptom spectrum.
When hot flashes occur during sleep, they're called night sweats. Night sweats can wake you abruptly, leave bedding soaked, and lead to chronic sleep loss — which in turn worsens fatigue, irritability, and brain fog the following day.
Why Hot Flashes Happen in Menopause
Hot flashes are thought to result from changes in your brain's temperature-regulation system — especially the hypothalamus — triggered by declining and fluctuating estrogen levels 1, 7.
The hypothalamus normally maintains a tight "comfort zone" between when your body decides it's too cold (and starts shivering) and when it decides it's too hot (and starts sweating). During perimenopause and menopause, falling estrogen narrows this comfort zone dramatically.
Tiny variations in core body temperature that you'd never have noticed before now trigger your body's full cooling response: the blood vessels near your skin dilate (the flush), your sweat glands activate (the sweat), and you feel a rush of heat.
Once the cooling response overshoots, you feel chilled.
This is also why perimenopausal hot flashes can be more severe than postmenopausal ones. In perimenopause, estrogen and progesterone don't simply decline — they swing wildly week to week. The hypothalamus is responding to a moving target.
A subset of neurons called KNDy neurons — a specific group of temperature-regulating nerves in the hypothalamus that become hyperactive when estrogen levels drop — appears to drive much of this dysfunction 1.
The newest non-hormonal treatments (such as fezolinetant) work by directly blocking the neurokinin-3 receptors on these neurons, helping stabilize the body's temperature-regulation signaling without supplementing hormones 5.
Other factors that can amplify or trigger hot flashes:
- Smoking — current and past smokers have more hot flashes
- Higher body weight / abdominal fat — particularly increases risk in early menopause
- Surgical menopause (ovary removal) — hot flashes start abruptly and tend to be more severe
- Population-level differences — Black women report more frequent and severe hot flashes on average, while some Asian populations report them less often. These are group trends and do not predict any one individual's experience
- Stress, hot environments, spicy food, hot drinks, alcohol, caffeine — common immediate triggers
Is This Normal? When to See a Doctor
Hot flashes are an extremely common, biologically expected symptom of the menopause transition — but "common" does not mean "you have to live with it." If hot flashes are interfering with your sleep, work, exercise, or relationships, that is a clinical reason to seek treatment, not just an inconvenience to tolerate.
Some studies have found that more frequent or severe vasomotor symptoms are associated with less favorable cardiovascular and metabolic risk markers.
This does not mean hot flashes themselves cause heart disease or stroke — it does mean it's worth discussing your overall cardiovascular risk picture with a clinician who treats the whole picture, not just the immediate discomfort.
Clinical Red Flags — Do NOT Assume Menopause
Most hot flashes are caused by hormonal changes — but not all. Seek prompt medical evaluation if you experience any of the following:
- Hot flashes that begin suddenly years after menopause (not a perimenopausal pattern that has continued)
- Hot flashes accompanied by chest tightness, shortness of breath, or pressure — possible cardiac symptoms
- Drenching night sweats with unintentional weight loss, fevers, or new lumps — possible signs of infection, thyroid disease, or malignancy
- Hot flashes plus a rapid, irregular, or pounding heartbeat that doesn't resolve when the flush passes
- Hot flashes that begin in your 30s without other perimenopausal signs — may indicate primary ovarian insufficiency or a thyroid disorder
- Hot flashes that begin after starting a new medication — examples include niacin, some antidepressants, tamoxifen, aromatase inhibitors, opioids, steroids, and some osteoporosis or diabetes medications
Other non-menopausal causes of hot flashes include thyroid disorders, certain rare tumors that can cause flushing (such as carcinoid tumors, pheochromocytoma, or medullary thyroid cancer), cancer treatments (such as tamoxifen and aromatase inhibitors), viral infections, anxiety disorders, and medication side effects.
A clinician can help distinguish.
What You Can Do About It
There are three categories of treatment, and most women benefit from a combination.
Quick Reference: Treatment Options for Moderate-to-Severe Hot Flashes
| Treatment | Type | FDA-approved for VMS? | Key benefit | Key consideration |
|---|---|---|---|---|
| Systemic hormone therapy (estradiol ± progestogen) | Hormonal | ✅ Yes | Most effective (~75% reduction) | Timing window; review CV/breast risk |
| Fezolinetant (Veozah) | Non-hormonal NK3 antagonist | ✅ Yes (2023) | Targets KNDy neurons | Liver-function monitoring required |
| Low-dose paroxetine (Brisdelle) | SSRI | ✅ Yes | Useful for breast cancer survivors | Avoid with tamoxifen |
| Venlafaxine, escitalopram, desvenlafaxine | SSRIs/SNRIs | Off-label | Dual benefit if mood symptoms also present | Variable efficacy |
| Gabapentin | GABA analogue | Off-label | Best when night sweats predominate | Daytime sedation; titrate |
| Oxybutynin | Antimuscarinic | Off-label | Helpful with overactive bladder | Anticholinergic side effects |
| Lifestyle (cooling, paced breathing, weight management) | Non-pharm | n/a | Adjunct foundation | Modest standalone effect |
Lifestyle changes (first line, low risk)
These won't eliminate hot flashes for most women, but they reduce frequency and severity for many — and they form the foundation of any treatment plan.
- Dress in layers with natural fibers (cotton, linen, wool) so you can shed quickly when a flash hits
- Keep your environment cool — a portable fan, AC, lighter bedding, cold water at the bedside
- Identify and avoid your triggers — most commonly coffee, red wine, spicy foods, hot showers, and warm rooms
- Address visceral (abdominal) fat — linked to more severe hot flashes. Midlife metabolism shifts make traditional diet-and-exercise less effective alone; medically supervised weight loss (including GLP-1 medications when indicated) often reduces hot flash burden
- Stop smoking — both current and past smoking increase hot flash burden
- Exercise regularly — for cardiovascular, metabolic, mood, and sleep benefits. Won't directly eliminate hot flashes for most women, but improves overall well-being 7
- Manage stress — mindfulness, cognitive-behavioral therapy (CBT), and clinical hypnosis all have evidence for reducing hot flash impact
For acute relief during a hot flash: practice paced breathing (slow, deep, diaphragmatic breaths at ~5-6 per minute), sip ice water, remove a layer, and use a portable neck fan or cooling towel to lower skin temperature quickly.
Non-hormonal prescription medications
For women who can't or prefer not to use hormone therapy — including many women with a history of breast cancer or blood clots — several non-hormonal options may help. The right choice depends on your medical history, including liver and kidney function, other medications, and cancer treatment history:
- Fezolinetant (Veozah™) — FDA-approved specifically for moderate-to-severe hot flashes; targets the KNDy neurons in the hypothalamus, no hormone exposure. Requires liver blood tests before and during treatment per current FDA labeling — the FDA has issued warnings about potential liver injury. Not appropriate for women with cirrhosis, severe renal impairment, or concurrent CYP1A2 inhibitors.
- Other non-hormonal neurokinin-targeting medications are being studied for vasomotor symptoms; availability and regulatory status should be verified before clinical use.
- Low-dose paroxetine (Brisdelle®) — the only SSRI FDA-approved specifically for hot flashes 6
- Other SSRIs/SNRIs (off-label): venlafaxine, desvenlafaxine, escitalopram, fluoxetine, citalopram 3. Important: paroxetine and fluoxetine can interfere with tamoxifen — choice should be coordinated with the oncology team for breast cancer survivors
- Gabapentin — often taken at bedtime; can be useful when hot flashes are predominantly nocturnal and disrupting sleep, but may cause dizziness, grogginess, and balance problems, so caution is needed especially in older patients
- Oxybutynin — option for women with concurrent overactive bladder
- Clonidine — an older option that is used less often now because it tends to be less effective and can cause side effects such as dry mouth, constipation, low blood pressure, and dizziness
Antidepressants used for hot flashes work in women without depression — they were studied in non-depressed populations specifically for vasomotor symptoms.
Hormone therapy / BHRT
The Menopause Society and ACOG agree: hormone therapy is the most effective treatment for moderate-to-severe vasomotor symptoms, and for women in early menopause without contraindications, the benefits typically outweigh the risks 2.
Hormone therapy is generally considered safest and most effective when started within 10 years of menopause or before age 60 ("the timing window") 2. Starting hormone therapy later can carry a different risk profile, which is one reason early evaluation is recommended.
Hormone therapy is not appropriate for everyone.
Important reasons it may be avoided include a history of estrogen-sensitive breast cancer, unexplained vaginal bleeding (which must be evaluated — often with pelvic ultrasound or endometrial biopsy — before starting hormone therapy), active liver disease, prior blood clots or stroke, known coronary disease in some patients, or pregnancy.
A clinician should review your personal risk profile before prescribing.
What you take depends on whether you still have a uterus:
- With uterus: bioidentical estradiol plus oral micronized progesterone (or another progestogen). The progestogen protects the uterine lining from thickening (endometrial hyperplasia) and prevents the increased risk of uterine cancer that can occur if estrogen is taken alone
- Without uterus (after hysterectomy): estradiol alone is typically sufficient. Exception: women who had a hysterectomy due to severe endometriosis may still be prescribed a progestogen alongside estrogen to suppress any residual endometriosis tissue
- A newer combination: estrogen plus bazedoxifene, a SERM (sold as Duavee®) — provides uterine protection without a traditional progestin (less commonly used in concierge BHRT practice; ask your clinician whether it's part of their formulary)
Hormone therapy can be delivered as pills, transdermal patches, sprays, gels, or a vaginal ring.
Some estrogen rings are systemic and can help hot flashes, while the more common low-dose vaginal estrogen rings are local treatments for dryness and urinary symptoms and do not reliably treat hot flashes. For hot flash relief specifically, systemic delivery is needed.
About half of women have at least a temporary return of hot flashes when stopping hormone therapy, so the decision to start, continue, and eventually taper is best made with a clinician who can re-evaluate periodically.
Therapies with limited or no evidence
The following are widely marketed but either lack strong evidence or have mixed/inconsistent results for hot flash relief, per the Menopause Society and Cleveland Clinic: black cohosh, evening primrose oil, vitamin E, dong quai, ginseng, maca, soy isoflavones, acupuncture, chiropractic care, cannabinoids, and chasteberry.
Phytoestrogen-rich foods (soy, flaxseed, chickpeas) are safe to eat but unlikely to deliver a meaningful effect on their own — and women with a history of estrogen-sensitive cancer should discuss soy supplementation with their oncologist before starting.
Get Started with JumpstartMD
If hot flashes are interfering with your sleep, work, or daily life, you don't have to wait them out.
JumpstartMD's perimenopause and menopause care is part of our broader Total Health Optimization approach — a medically-supervised bioidentical hormone therapy program delivered by an expert team of licensed clinicians (under physician oversight), supported by lifestyle coaching for the behavioral side of care. Treatment balances five key hormones — estrogen, progesterone, DHEA, testosterone, and thyroid — through pills, creams, patches, injections, or subcutaneous pellet therapy (in-person visits only).
The program follows a structured pathway: a phone connection with our team, an online health questionnaire, comprehensive hormone labs at Quest Laboratories, a clinical consultation to review results, a personalized treatment plan, and regular follow-ups to fine-tune dosing as your body responds. Care is delivered in-person at our 14 California clinics or online from anywhere in California. When weight or metabolic health is contributing to your symptoms, BHRT is coordinated with our medical weight loss program in the same care plan.
Membership benefits include comprehensive lab testing, ongoing support and monitoring, exclusive member pricing on products, and concierge medical insurance claims assistance for PPO out-of-network plans (FSA/HSA accepted).
Book FREE Consultation
Share your details and a JumpstartMD team member will reach out shortly. Or call 408.478.3496 for your free, no-obligation consultation.
Frequently Asked Questions
How do I stop a hot flash in the moment?
If you feel one coming on: practice paced breathing (slow, deep, abdominal breathing at about 5-6 breaths per minute), drink ice water, remove a layer of clothing, and use a portable neck fan or cooling towel to rapidly lower skin temperature. These techniques don't prevent future hot flashes, but they can shorten and soften the one happening now. For ongoing reduction in frequency and severity, see the treatment options above.
How long do hot flashes last?
Each individual episode lasts 1 to 5 minutes. The condition itself — having recurring hot flashes — often continues for several years, and in some women a decade or longer. Frequency and severity are usually highest in the two years after menopause and gradually ease in the years following.
Will my hot flashes return if I stop hormone therapy?
About half of women experience at least a temporary return of hot flashes when discontinuing hormone therapy. Tapering the dose gradually may help, though the evidence for tapering versus stopping outright is limited. If hot flashes return and remain bothersome, treatment can be restarted. Periodic re-evaluation with your clinician is the right approach.
Can I take an antidepressant for hot flashes if I'm not depressed?
Yes. Several SSRIs and SNRIs were tested in women without depression specifically as hot flash treatments, and they're effective for vasomotor symptoms regardless of mood status 3. They're often a useful option for women who can't or prefer not to use hormone therapy, including many women with a history of breast cancer. However, some antidepressants — particularly paroxetine and fluoxetine — can interact with tamoxifen, so medication choice should be coordinated with the prescribing oncology team.
Do hot flashes mean I'm at higher risk for heart disease?
Newer research suggests that women with moderate-to-severe hot flashes may have a higher long-term risk of cardiovascular disease, stroke, and metabolic syndrome. This is one of the reasons the Menopause Society now treats severe hot flashes as a clinical issue worth addressing, not just a quality-of-life nuisance. If your hot flashes are severe, this is a reason to discuss cardiovascular risk screening with your doctor.
Are bioidentical hormones safer than traditional hormone therapy?
"Bioidentical" hormones have the same molecular structure as the hormones your body produces. FDA-approved "bioidentical" products (such as estradiol patches/gels and oral micronized progesterone) are different from compounded hormones marketed as customized alternatives. The FDA-approved versions are well-studied with an established safety profile. Compounded formulations from compounding pharmacies are not FDA-regulated for dosing consistency, and the major medical societies recommend FDA-approved options when possible. The "bioidentical vs synthetic" question is more nuanced than marketing usually portrays — your clinician can help you understand the actual clinical evidence for each option.
References
- R. Bansal, N. Aggarwal, "Menopausal hot flashes: a concise review," Journal of Mid-life Health, vol. 10, no. 1, pp. 6-13, Jan.-Mar. 2019, [Online]. Available: https://doi.org/10.4103/jmh.JMH_7_19. PMID: 31001050. [Accessed: Apr. 26, 2026]. ↩
- The North American Menopause Society, "The 2022 hormone therapy position statement of The North American Menopause Society," Menopause, vol. 29, no. 7, pp. 767-794, Jul. 2022, [Online]. Available: https://doi.org/10.1097/GME.0000000000002028. PMID: 35797481. [Accessed: Apr. 26, 2026]. ↩
- The North American Menopause Society, "The 2023 nonhormone therapy position statement of The North American Menopause Society," Menopause, vol. 30, no. 6, pp. 573-590, Jun. 2023, [Online]. Available: https://doi.org/10.1097/GME.0000000000002200. PMID: 37252752. [Accessed: Apr. 26, 2026]. ↩
- S. R. El Khoudary, B. Aggarwal, T. M. Beckie, H. N. Hodis, A. E. Johnson, R. D. Langer, M. C. Limacher, J. E. Manson, M. L. Stefanick, M. A. Allison; American Heart Association Prevention Science Committee, "Menopause transition and cardiovascular disease risk: implications for timing of early prevention — a scientific statement from the American Heart Association," Circulation, vol. 142, no. 25, pp. e506-e532, Dec. 22, 2020, [Online]. Available: https://doi.org/10.1161/CIR.0000000000000912. PMID: 33251828. [Accessed: Apr. 26, 2026]. ↩
- U.S. Food and Drug Administration, "Highlights of Prescribing Information: Veozah (fezolinetant) tablets, for oral use," [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216578s000lbl.pdf. [Accessed: Apr. 26, 2026]. ↩
- U.S. Food and Drug Administration, "Highlights of Prescribing Information: Brisdelle (paroxetine) capsules," [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204516s000lbl.pdf. [Accessed: Apr. 26, 2026]. ↩
- S. Witkowski, R. Evard, J. J. Rickson, Q. White, L. Sievert, "Physical activity and exercise for hot flashes: trigger or treatment?," Menopause, vol. 30, no. 2, pp. 218-224, Feb. 2023, [Online]. Available: https://doi.org/10.1097/GME.0000000000002126. PMID: 36696647. [Accessed: Apr. 26, 2026]. ↩